Capricor EVP exercises options, sells 25K shares
CAPRICOR THERAPEUTICS, INC. executive vice president and general counsel Karen Krasney reported an exercise-and-sell transaction in company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CAPRICOR THERAPEUTICS, INC. executive vice president and general counsel Karen Krasney reported an exercise-and-sell transaction in company stock. She exercised stock options covering a total of 25,000 shares of common stock at exercise prices of $1.39, $3.74 and $3.18 per share.
On the same day, she sold 25,000 shares of common stock at a weighted average price of $30.1174 per share, with individual trades ranging from $30.00 to $30.31. Following these transactions, she directly holds 30,547 shares of CAPRICOR common stock. The sale was made under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025, indicating the timing was set in advance.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 693 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 21,488 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 2,819 | $0.00 | $0.00 |
| Exercise | Common Stock | 693 | $1.39 | $963.27 |
| Exercise | Common Stock | 21,488 | $3.74 | $80K |
| Exercise | Common Stock | 2,819 | $3.18 | $9K |
| Sale | Common Stock | 25,000 | $30.1174 | $753K |
Footnotes (6)
- F1. Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2. The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.31, inclusive.
- F3. This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
- F4. Shares vested 1/48th on the first day of each month commencing February 1, 2018.
- F5. Shares vested 1/48th on the first day of each month commencing February 1, 2021.
- F6. Shares vested 1/48th on the first day of each month commencing February 1, 2022.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
reverse stock split financial
stock option financial
exercise or conversion of derivative security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CAPR executive Karen Krasney report on this Form 4?
What stock options did Karen Krasney exercise in this CAPR Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.